NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

Vela Diagnostics Great Basin System

Business Name: Vela Diagnostics Great Basin System
Business Genre:
Business Description:

The company was basec in Singapore and founded in 2011 with approximately 200 employeeds worldwide. The company focuses on intergrated real-time PCR techniques and Next-Generation Sequencing. Vela Diagnostics acquired Great Basin Scientifc, a US-based public company in November 2018 to extend their existing bussiness in virology and oncology to microbiology. [2] [3]

State: Singapore
Data/Evidence of Effectiveness: N/A
Complimentary Products Needed to Perform Test: in development
Setting of Care: N/A
Current Status / Clinical Development Stage / Expected Milestones: Report in Feburary indicated Vela Diagnostics and Great Basin Scientific are co-developing a CoV-19 testing pannel used on Great Basin system. [4]
Funding & Ownership : Private, raised a total of $225K in funding over one round by Biomedical Advanced Research and Development Authority (BARDA) on April 20. [1]
Business Model: Velax Diagnostics provided two workflows for diagnostics: qPCR and NGS based on fully automated Sentosa SX101 platform. The platform can provides solutions for diagnostics of virology and oncology. [5]
IP: N/A
History & Origins : The company also developed another CoV-19 testing kit ViroKey SARS-CoV-2 RT-PCR Test used on Applied Biosystems® 7500 Fast Dx Real-Time PCR System or the Sentosa® SA201 Real-Time PCR Instrument. The product is under pre-EUA for prescription use only. The product is a RT-PCR testing for detection of nucleic acid from CoV-19. [6]
Date EUA Issued: in development
Sources: “[1] https://www.crunchbase.com/organization/vela-diagnostics-pte-ltd#section-overview [2] https://www.veladx.com/news-reader/items/vela-diagnostics-announces-launch-of-the-great-basin-system.html [3] https://www.veladx.com/company/at-a-glance.html [4] https://www.veladx.com/news-reader/items/vela-diagnostics-submitting-novel-coronavirus-diagnostic-test-to-fda-for-emergency-use-authorization-update.html [5] https://www.veladx.com/products.html [6] https://www.veladx.com/product/qpcr-respiratory-viruses/virokey-sars-cov-2-rt-pcr-test-pre-EUA.html [7] https://www.veladx.com/company/key-management.html [8] https://www.veladx.com/products/near-patient-testing.html”
Organization: Sam Dajani (CEO), Charlie Lee (Head of Research and Development) [7]
Time to Result: deliver a diagnostic result (6 PCR assays) under 90 min [4] [8]
Test Sample Type: N/A
Technology Overview: PCR amplification for CoV-19 specific nucleic acid
Testing Type: nucleic acid detection
Test Category: RT-PCR
Test Name: SARS-CoV-2 Direct Test
Clinical Application & Need: acute infection

Send Message to listing owner